Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Piperaquine is an antimalarial agent first synthesized in the 1960's and used throughout China . Its use declined in the 1980's as piperaquine resistant strains of Plasmodium falciparum appeared and... It has come back into use in combination with the artemisinin derivative DB11638 as part of the combination product Eurartesim.
- Mechanism
- Curator reviewed
The mechanism of piperaquine inhibition of the haem detoxification pathway is unknown but is expected to be similar to that of DB00608.
- Primary indication
- For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg.Curator reviewed · 1 structured indication
- Formula / weight
- C29H32Cl2N6 · 535.52 g/mol (avg)
- First approval
- European Union, 2021
- Brand names
- Eurartesim
Resolves to
UCRHFBCYFMIWHC-UHFFFAOYSA-NSMILESClC1=CC2=C(C=C1)C(=CC=N2)N1CCN(CCCN2CCN(CC2)C2=CC=NC3=C2C=CC(Cl)=C3)CC1What you can answer from here — as of September 23, 2026
Which drugs share a target with Piperaquine, and which of those have an active Phase 3 trial?